PerkinElmer open to more 'informatics' buyouts; Euerka Genomics snags $750K SBIR grant;

> Eureka Genomics, a provider of bioinformatics analysis, has snagged a two-year, $750,000 Small Business Innovation Research grant from the Department of Homeland Security to develop tools for use in finding rare variants of the anthrax pathogen, Bacillus anthracis. Release

> PerkinElmer ($PKI) CEO Rob Friel still has an appetite for buying "informatics" companies. Item

> Second Genome, a start-up that uses a proprietary assay and bioinformatics to study microbes, has brought in $5 million from investors. Report

> Stakeholders in The Netherlands have grown a national network for reporting medication errors. Abstract

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.